Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Katsuya, Nishida"'
Autor:
Tomoyuki Ishimoto, Miki Oono, Seiji Kaji, Takashi Ayaki, Katsuya Nishida, Itaru Funakawa, Takakuni Maki, Shu-ichi Matsuzawa, Ryosuke Takahashi, Hodaka Yamakado
Publikováno v:
Molecular Brain, Vol 17, Iss 1, Pp 1-13 (2024)
Abstract The aggregated alpha-synuclein (αsyn) in oligodendrocytes (OLGs) is one of the pathological hallmarks in multiple system atrophy (MSA). We have previously reported that αsyn accumulates not only in neurons but also in OLGs long after the a
Externí odkaz:
https://doaj.org/article/cd30b625e77b48f48134f51505938d29
Autor:
Kento Sakashita, Katsuya Nishida, Yu Takenaka, Ichiro Yokota, Hiroshi Yamasaki, Keisuke Nishimoto, Kunihiko Kawamoto, Maki Mitani, Itaru Funakawa, Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata, Naonobu Futamura
Publikováno v:
Case Reports in Neurology, Vol 14, Iss 3, Pp 494-500 (2023)
Anti-metabotropic glutamate receptor 1 (mGluR1) encephalitis is a rare autoimmune disorder manifesting with cerebellar syndrome. Patients with mGluR1 encephalitis have been treated with immunomodulatory therapies; however, little is known about the e
Externí odkaz:
https://doaj.org/article/29041873b5c1419baea79794f9bacd6b
Autor:
Hiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson, Hisatomo Kowa, Tatsushi Toda
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-13 (2022)
Abstract The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an a
Externí odkaz:
https://doaj.org/article/4c4ffbf507a846fca4aa61e375060fe2
Autor:
Hiroyuki Todo, Katsuya Nishida, Ryuki Ando, Hiroshi Yamasaki, Naonobu Futamura, Itaru Funakawa
Publikováno v:
Annals of Indian Academy of Neurology, Vol 22, Iss 4, Pp 482-484 (2019)
Background: Although muscle ultrasound (MUS) is known to facilitate the diagnosis and evaluation of the severity of amyotrophic lateral sclerosis (ALS), the number of fasciculation has been scarcely examined as a predictive marker of the prognosis in
Externí odkaz:
https://doaj.org/article/da7311be712a49bda36d6e170ea3653c
Autor:
Katsuya Nishida, Naonobu Futamura
Publikováno v:
Stroke. 54
Publikováno v:
Parkinsonism & Related Disorders. 97:107-111
Tracheostomy invasive ventilation (TIV) is therapeutic intervention to prolong survival. However, few reports have addressed TIV in multiple system atrophy (MSA). This study sought to evaluate the impact of TIV on survival in MSA patients.This retros
Publikováno v:
Rinsho shinkeigaku = Clinical neurology. 62(4)
A 75-year-old man with a history of hypertension developed weakness and sensory disturbance in the extremities 1 week after upper respiratory tract infection and faced difficulty walking. Screening at the time of hospital admission revealed an incide
Publikováno v:
Neurology. 97:600-601
A 78-year-old woman progressively developed right-sided blindness, total ophthalmoplegia, painful facial palsy, and deafness with erythema 8 months before death. MRI showed enlarged right trigeminal nerve with contrast enhancement. FDG-PET showed abn
Publikováno v:
Neurology and Therapy
Introduction Camptocormia (severe bending of the spine) is a debilitating complication of Parkinson’s disease (PD) without established treatment. Botulinum toxin (BT) may be beneficial, but data is scarce regarding the efficacy of administration of
Autor:
Hiroshi Yamasaki, Hiroyuki Todo, Naonobu Futamura, Katsuya Nishida, Ryuki Ando, Itaru Funakawa
Publikováno v:
Annals of Indian Academy of Neurology, Vol 22, Iss 4, Pp 482-484 (2019)
Annals of Indian Academy of Neurology
Annals of Indian Academy of Neurology
Background: Although muscle ultrasound (MUS) is known to facilitate the diagnosis and evaluation of the severity of amyotrophic lateral sclerosis (ALS), the number of fasciculation has been scarcely examined as a predictive marker of the prognosis in